(:AVDR)

Jun 20, 2022 01:01 am ET
New Age Alpha Announces Closure of 2 AVDR ETFs
New Age Alpha Trust announced today the impending closure and liquidation of the AVDR US LargeCap Leading ETF (CBOE: AVDR) and the AVDR US LargeCap ESG ETF (CBOE: AVDG). The New Age Alpha Trust Board of Trustees approved the closing and subsequent liquidation of AVDR and AVDG. Each Fund’s last day of trading will be July 11, 2022, which will also be the final day for creations or redemptions by authorized participants. Each Fund will cease operations, withdraw its assets, and distribute the remaining proceeds to shareholders on July 18, 2022.
Sep 09, 2020 09:48 am ET
INVESTIGATION ALERT: Nationally Ranked Litigation Firm Labaton Sucharow Announces Investigation of the Merger of Avedro, Inc. and Glaukos Corporation and Strongly Encourages Investors to Contact the F
Labaton Sucharow LLP, a leading investor rights law firm, announces it is investigating potential securities claims on behalf of former shareholders of Avedro Inc. (NASDAQ: AVDR) concerning allegations that Glaukos Corp. (NASDAQ: GKOS), may have issued materially misleading business information to the investing public in connection with its November 2019 merger with Avedro.
Sep 08, 2020 09:44 am ET
INVESTIGATION ALERT: Nationally Ranked Litigation Firm Labaton Sucharow Announces Investigation of the Merger of Avedro, Inc. and Glaukos Corporation and Strongly Encourages Investors to Contact the F
Labaton Sucharow LLP, a leading investor rights law firm, announces it is investigating potential securities claims on behalf of former shareholders of Avedro Inc. (NASDAQ: AVDR) concerning allegations that Glaukos Corp. (NASDAQ: GKOS), may have issued materially misleading business information to the investing public in connection with its November 2019 merger with Avedro.
Nov 06, 2019 08:30 am ET
Avedro, Inc. Announces Third Quarter 2019 Financial Results
Avedro, Inc. (Nasdaq: AVDR) (Avedro), today reported financial results for the quarter ended September 30, 2019. Third Quarter Financial ResultsRevenue for the quarter ended September 30, 2019 increased 38% to $11.0 million, from $8.0 million...
Oct 28, 2019 10:28 am ET
Bragar Eagel & Squire, P.C. Announces that it Is Investigating the Boards of Directors of Avedro, Dova, SemGroup, and United Community on behalf of Stockholders and Encourages Investors to Contact the
Bragar Eagel & Squire, P.C. announces to investors that it is investigating potential claims on behalf of stockholders of Avedro, Inc. (NASDAQ: AVDR), Dova Pharmaceuticals, Inc. (NASDAQ: DOVA), SemGroup Corporation (NYSE: SEMG), and United...
Oct 24, 2019 02:06 pm ET
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts
Rigrodsky & Long, P.A. announces that it is investigating: Innophos Holdings, Inc. (NASDAQ GS: IPHS) regarding possible breaches of fiduciary duties and other violations of law related to Innophos’ agreement to be acquired by One Rock Capital...
Oct 15, 2019 10:12 am ET
Shareholder Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – SRCI, AVDR, MCRN, PSDO
Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: SRC Energy Inc. (NYSE: SRCI)The investigation concerns whether SRC Energy and its board of directors violated the federal securities laws and/or...
Oct 09, 2019 04:30 pm ET
Avedro Announces Schedule of Events at the American Academy of Ophthalmology Annual Meeting
Avedro, Inc. (Nasdaq: AVDR) (Avedro) today announced its schedule of scientific and educational programs focused on corneal cross-linking and keratoconus during AAO 2019, the American Academy of Ophthalmology’s (AAO) 123rd annual meeting that is...
Sep 27, 2019 08:37 pm ET
AVEDRO, INC. SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces an Investigation of Avedro, Inc. (AVDR) Over the Proposed Merger of the Company with Glaukos Corporation
NEW YORK, Sept. 27, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating the proposed merger of Avedro, Inc. ("Avedro" or the "Company") (NASDAQ: AVDR) with Glaukos Corporation ("Glaukos").
Sep 23, 2019 01:11 pm ET
Shareholder Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – AVDR, PSDO, PVTL, SRCI
Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Avedro, Inc. (NASDAQ: AVDR) The investigation concerns whether Avedro and its board of directors violated the federal securities laws and/or...
Sep 19, 2019 02:16 pm ET
Bragar Eagel & Squire, P.C. Announces that it is Investigating the Boards of Directors of Avedro, Frederick County Bancorp, Presidio, and Wesco on behalf of Stockholders and Encourages Investors to Co
Bragar Eagel & Squire, P.C. announces to investors that it is investigating potential claims on behalf of stockholders of Avedro, Inc. (NASDAQ: AVDR), Frederick County Bancorp, Inc. (Other OTC: FCBI), Presidio, Inc. (NASDAQ: PSDO), and Wesco...
Sep 19, 2019 12:51 pm ET
SEMG, PVTL, FCSC and AVDR SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts
Rigrodsky & Long, P.A. announces that it is investigating: SemGroup Corporation (NYSE: SEMG) regarding possible breaches of fiduciary duties and other violations of law related to SemGroup’s agreement to be acquired by Energy Transfer LP....
Sep 17, 2019 10:44 am ET
Shareholder Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – CBM, WAIR, AVDR, PSDO
Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Cambrex Corporation (NYSE: CBM)The investigation concerns whether Cambrex and its board of directors violated the federal securities laws and/or...
Sep 11, 2019 06:11 pm ET
PSDO, GCI, MCRN and AVDR SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts
Rigrodsky & Long, P.A. announces that it is investigating: Presidio, Inc. (NASDAQ GS: PSDO) regarding possible breaches of fiduciary duties and other violations of law related to Presidio’s agreement to be acquired by funds advised by BC Partners....
Sep 11, 2019 04:30 pm ET
Boost Epi-On™ Corneal Cross-Linking Data to Be Presented at the 37th Congress of the ESCRS
Avedro, Inc. (Nasdaq: AVDR) (Avedro), today announced the inclusion of a wide array of Boost Epi-On cross-linking (CXL) presentations in the scientific and educational programs at the 10th EU Cornea Congress and the 37th Congress of the European...
Sep 11, 2019 01:20 pm ET
Shareholder Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – PSDO, GCI, AVDR
Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Presidio, Inc. (NASDAQ: PSDO)The investigation concerns whether Presidio and its board of directors violated the federal securities laws and/or...
Sep 04, 2019 09:39 am ET
PVTL, CBM, VSI and AVDR SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts
Rigrodsky & Long, P.A. announces that it is investigating: Pivotal Software (NYSE: PVTL) regarding possible breaches of fiduciary duties and other violations of law related to Pivotal’s agreement to be acquired by VMware, Inc. (NYSE: VMW)....
Sep 03, 2019 09:00 am ET
Merger Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – VSI, WAIR, AVDR, PSDO
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Vitamin Shoppe, Inc. (NYSE: VSI)The investigation concerns whether Vitamin Shoppe and its board of directors violated the federal...
Aug 21, 2019 12:26 pm ET
MERGER ALERT – PSDO and AVDR: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
The following statement is being issued by Levi & Korsinsky, LLP: Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholders of the following publicly-traded companies. Presidio, Inc. (NASDAQGS: PSDO) Merger...
Aug 19, 2019 12:42 pm ET
PSDO, ASV, WAIR, and AVDR SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts
Rigrodsky & Long, P.A. announces that it is investigating: Presidio, Inc. (NASDAQ GS: PSDO) regarding possible breaches of fiduciary duties and other violations of law related to Presidio’s agreement to be acquired by funds advised by BC Partners....
Aug 15, 2019 04:35 pm ET
MERGER ALERT – VSI, AVDR, and CDOR: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
The following statement is being issued by Levi & Korsinsky, LLP: Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholders of the following publicly-traded companies. Vitamin Shoppe, Inc. (NYSE: VSI) Merger...
Aug 13, 2019 05:56 pm ET
AVEDRO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avedro, Inc. - AVDR
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Avedro, Inc. (NasdaqGM: AVDR) to Glaukos Corporation (NYSE: GKOS). Under the terms of the proposed transaction, shareholders of Avedro will receive only 0.365 shares of Glaukos for each share of Avedro that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
Aug 13, 2019 12:32 pm ET
TRCB, AVDR, CBM, and NCI SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts
Rigrodsky & Long, P.A. announces that it is investigating: Two River Bancorp (NASDAQ GM: TRCB) regarding possible breaches of fiduciary duties and other violations of law related to Two River’s agreement to be acquired by OceanFirst Financial...
Aug 13, 2019 11:01 am ET
MERGER ALERT –NCI, AVDR, and CBM: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
The following statement is being issued by Levi & Korsinsky, LLP: Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholders of the following publicly-traded companies. Navigant Consulting, Inc. (NYSE: NCI)...
Aug 12, 2019 10:55 am ET
Avedro Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Avedro, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – AVDR
Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Avedro, Inc. (NASDAQ: AVDR) to Glaukos Corporation is fair to Avedro shareholders. Under the terms of the merger agreement, Avedro shareholders will receive...
Aug 09, 2019 08:00 pm ET
URGENT: Monteverde & Associates PC is Investigating the Following Transaction
NEW YORK, Aug. 9, 2019 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:
Aug 08, 2019 08:08 pm ET
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Avedro, Inc. (NASDAQ: AVDR) on Behalf of Avedro Shareholders and Encourages Avedro Investors to Contact the Firm
NEW YORK, Aug. 8, 2019 /PRNewswire/ -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Avedro, Inc. (NASDAQ: AVDR) on behalf of Avedro shareholders concerning the proposed merger with Glaukos Corporation.
Aug 08, 2019 02:03 pm ET
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Avedro, Inc.
NEW YORK, Aug. 8, 2019 /PRNewswire/ -- Rowley Law PLLC is investigating potential claims against Avedro, Inc. (NASDAQ: AVDR) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Glaukos Corporation (NYSE: GKOS). Stockholders will receive 0.365 shares of Glaukos Corporation common stock for each share of Avedro, Inc. stock that they hold. The transaction is valued at approximately $395 million and is expected to close in the fourth quarter of 2019.
Aug 08, 2019 11:32 am ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Avedro, Inc. to Glaukos Corporation is Fair to Shareholders
The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Avedro, Inc. (“Avedro” or the “Company”) (NASDAQGM: AVDR) stock prior to August 7, 2019. You are hereby notified that Levi & Korsinsky,...
Aug 07, 2019 08:03 pm ET
Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Avedro, Inc. has obtained a Fair Price in its sale to Glaukos Corporation
MILWAUKEE, Aug. 7, 2019 /PRNewswire/ -- Ademi & O'Reilly, LLP is investigating Avedro (Nasdaq: AVDR) for possible breaches of fiduciary duty and other violations of the law in connection with the sale of Avedro to Glaukos.
Aug 07, 2019 04:15 pm ET
Avedro, Inc. Announces Second Quarter 2019 Financial Results
Avedro, Inc. (Nasdaq: AVDR) (Avedro), today reported financial results for the quarter ended June 30, 2019. The company’s earnings call and webcast previously scheduled for tomorrow, Thursday, August 8 will now occur today, Wednesday, August 7 at...
Aug 07, 2019 04:10 pm ET
Glaukos and Avedro Announce Definitive Acquisition Agreement
Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, and Avedro, Inc. (Nasdaq: AVDR), a leading hybrid ophthalmic pharmaceutical and medical technology company focused on treating corneal disease and disorders, today announced that the companies have entered into a definitive merger agreement under which Glaukos will acquire Avedro in an all-stock transaction. The transaction, which is subject to Avedro stockholder approval along with other customary closin
Jul 25, 2019 04:05 pm ET
Avedro, Inc. to Report Second Quarter 2019 Financial Results on August 8, 2019
Avedro, Inc. (Nasdaq: AVDR) (“Avedro”), today announced that it will release financial results for the second quarter of 2019 after the close of trading on Thursday, August 8, 2019.  Avedro’s management team will host a corresponding conference...
May 20, 2019 04:05 pm ET
Avedro, Inc. to Present at the Guggenheim MedTech Disruptors Summit
Avedro, Inc. (Nasdaq: AVDR) (“Avedro”), today announced the company will be participating in the upcoming Guggenheim MedTech Disruptors Summit in New York, NY. Avedro’s management is scheduled to present on Wednesday, May 29, 2019, at 4:10 PM...
May 09, 2019 04:05 pm ET
Avedro, Inc. Announces First Quarter 2019 Financial Results
Avedro, Inc. (Nasdaq: AVDR) (Avedro) today reported financial results for the quarter ended March 31, 2019. Recent Highlights First quarter 2019 revenue of $8.8 million – an increase of 70% year over yearGross margin increased to 74.0% vs....
May 01, 2019 04:05 pm ET
Avedro Completes Enrollment in Pivotal U.S. Phase 3 Epi-On Corneal Cross-Linking Clinical Trial for Progressive Keratoconus
Avedro, Inc. (Nasdaq: AVDR) (Avedro), today announced that the company has completed patient enrollment in a pivotal Phase 3 clinical trial to evaluate the safety and efficacy of an epithelium-on (Epi-On) corneal cross-linking procedure for the...
Apr 30, 2019 04:05 pm ET
Avedro, Inc. to Present at the Bank of America Merrill Lynch Health Care Conference
Avedro, Inc. (Nasdaq: AVDR) (“Avedro”), today announced the company will be participating in the upcoming Bank of America Merrill Lynch Health Care conference in Las Vegas, NV. Avedro’s management is scheduled to present on Tuesday, May 14, 2019...
Apr 29, 2019 04:05 pm ET
Avedro Announces Comprehensive Educational Schedule at ASCRS Annual Meeting
Avedro, Inc. (Nasdaq: AVDR) (Avedro) today announced the inclusion of a wide range of corneal cross-linking and keratoconus scientific and educational programs at the 2019 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting...
Apr 25, 2019 04:05 pm ET
Avedro, Inc. to Report First Quarter 2019 Financial Results on May 9, 2019
Avedro, Inc. (Nasdaq: AVDR) (“Avedro”) today announced that it will release financial results for the first quarter of 2019 after the close of trading on Thursday, May 9, 2019. Avedro’s management team will host a corresponding conference call...
Apr 22, 2019 04:05 pm ET
Avedro to Present Research on Proprietary Corneal Cross-Linking Technologies at 2019 ARVO Annual Meeting
Avedro, Inc. (Nasdaq: AVDR) (Avedro), today announced that three abstracts highlighting proprietary cross-linking technologies being developed by Avedro have been accepted for poster presentations at the upcoming 2019 Association for Research in...
Apr 05, 2019 07:00 am ET
Avedro Reaches Reimbursement Milestone for Its FDA-Approved Procedure for Progressive Keratoconus
Avedro, Inc., (Avedro or the company), today announced that four new providers --Providence Health Plan in the Pacific Northwest, Health New England, HealthPartners Minnesota and Public Employees Health Plan (PEHP) in Utah--have issued positive...
Mar 21, 2019 04:05 pm ET
Avedro, Inc. Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Full Year 2019 Financial Outlook
Avedro, Inc. (Nasdaq: AVDR) (“Avedro”), a leading commercial-stage ophthalmic medical technology company focused on treating corneal ectatic disorders and improving vision to reduce dependency on eyeglasses or contact lenses, today reported...
Mar 13, 2019 04:05 pm ET
Avedro, Inc. Announces Appointment of Patrick B. Jacques as Vice President of Sales
Avedro, Inc. (Nasdaq: AVDR) (“Avedro”), a leading commercial-stage ophthalmic medical technology company focused on treating corneal ectatic disorders and improving vision to reduce dependency on eyeglasses or contact lenses, today announced the...
Feb 28, 2019 04:05 pm ET
Avedro, Inc. to Report Fourth Quarter and Full Year 2018 Financial Results on March 21, 2019
Avedro, Inc. (Nasdaq: AVDR) (“Avedro”), a leading commercial-stage ophthalmic medical technology company focused on treating corneal ectatic disorders and improving vision to reduce dependency on eyeglasses or contact lenses, today announced that...
Feb 13, 2019 09:19 pm ET
Avedro Announces Pricing of Initial Public Offering
Avedro, Inc. (Nasdaq: AVDR) (“Avedro”), a leading commercial-stage ophthalmic medical technology company focused on treating corneal ectatic disorders and improving vision to reduce dependency on eyeglasses or contact lenses, today announced the...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.